Publications


Synergic Suppressive Effect of Silodosin and Imidafenacin on Non-Voiding Bladder Contractions in Male Rats with Subacute Bladder Outlet Obstruction.
Low Urin Tract Symptoms 2017 May 27;9(2):94-101. Epub 2015 Jul 27.
Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.

Biphasic decline in renal function after radical cystectomy with urinary diversion.
Int J Clin Oncol 2017 Apr 17;22(2):359-365. Epub 2016 Oct 17.
Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.



A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor.
Cancer Sci 2017 Jan 1;108(1):32-41. Epub 2016 Dec 1.
Department of Geriatric Medicine and Anti-Aging Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.











Selective inhibitory effect of imidafenacin and 5-hydroxymethyl tolterodine on capsaicin sensitive C fibers of the primary bladder mechanosensitive afferent nerves in the rat.
J Urol 2015 Apr 16;193(4):1423-32. Epub 2014 Sep 16.
Departments of Continence Medicine and Urology (TF, MS, HF, YH), University of Tokyo Graduate School of Medicine, Tokyo, Japan. Electronic address:



Robot-assisted versus other types of radical prostatectomy: population-based safety and cost comparison in Japan, 2012-2013.
Cancer Sci 2014 Nov 25;105(11):1421-6. Epub 2014 Sep 25.
Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA; Department of Urology, The University of Tokyo, Tokyo, Japan.


Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer.
BMC Urol 2014 Oct 16;14:81. Epub 2014 Oct 16.
Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.



Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer.
BMC Urol 2014 Jan 29;14:13. Epub 2014 Jan 29.
Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Reduction of prostate cancer incidence by naftopidil, an α1 -adrenoceptor antagonist and transforming growth factor-β signaling inhibitor.
Int J Urol 2013 Dec 21;20(12):1220-7. Epub 2013 Apr 21.
Department of Urology, The University of Tokyo Hospital, Tokyo, Japan; Department of Urology, The Fraternity Memorial Hospital, Tokyo, Japan.






Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
Clin Cancer Res 2006 Nov;12(22):6791-9
Molecular Neurosurgery Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.

OF